Obesity Treatment Market Overview
The Obesity Treatment Market is projected to grow at a CAGR of 16.7% during forecast period. Obesity is on the rise due to sedentary lives, bad eating habits, and a lack of physical activity, and it is one of the primary factors driving market revenue growth.
Increased commercial availability of weight-management programs, growing preference for technologically advanced weight-loss devices and equipment, and an increase in a government attempt to raise awareness regarding obesity and its negative health consequences all contribute to the global market’s expansion. Furthermore, rising health and fitness trends, like rising gym culture, cosmetic concerns, particularly among millennials, rising predisposition toward weight-loss surgeries, and rising healthcare expenditure, generate obesity treatment market growth prospects.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/5872
Obesity is a medical disorder caused by the body’s fat cells expanding in size. This disorder has been linked to several health issues, including diabetes, cardiovascular disease, high blood pressure, and various cancers. Physical inactivity, lack of sleep, and excessive junk food consumption contribute to obesity.
Obesity treatment is said to be based on lifestyle modifications such as a healthy diet and regular exercise. Dietary adjustments increased physical activity, and behavioural changes have all been shown to help improve and avoid obesity-related health problems. Physicians may recommend specialized weight-loss methods and drugs in more serious circumstances. Orlistat (Xenical, Alli), phentermine-topiramate (Qsymia), naltrexone-bupropion (Contrave), semaglutide (Wegovy), and liraglutide are some of the most well-known FDA-approved weight-loss medicines (Saxenda).
Obesity Treatment Market Segmentation
The obesity treatment market is divided into three categories: lifestyle changes, surgery and implant technologies, and pharmacological treatments. Dietary and exercise modifications are part of a lifestyle transformation. In 2015, the dietary sector had a sizable market share, likely to grow during the forecast period. The low cost of therapy, growing health consciousness among individuals, and acceptance that it is easier to reduce calorie intake to a greater extent than to burn more calories through increased exercise could all contribute to the segment’s prediction to rise.
Electrical stimulation systems, gastric bypass surgery, gastric band, gastric balloon, and gastric emptying system are the different types of surgery and implant devices.
Obesity Treatment Market Regional Overview
The obesity treatment market is divided into four regions: North America, Europe, Asia Pacific, and the rest of the world. Because of the rise in childhood obesity rates, strong government backing and funding, expansion in the obese population, lifestyle changes, increased participation in health clubs, and technical improvements in this area, North America accounted for a substantial proportion of the market in 2014.
Because of considerable R&D efforts made to develop sensible and effective obesity treatment techniques, North America is anticipated to continue its position. Due to rising drug demand, commercialization of minimally invasive surgical procedures, and increased awareness of the hazards linked to obesity. The Asia Pacific is expected to develop at a rapid pace. Furthermore, during the predicted period, a poor diet and sedentary lifestyle are likely to increase the population of fat persons.
Obesity Treatment Market Key Players
Some of the key players for the global obesity treatment market are VIVUS, Inc. (U.S.), Arena Pharmaceuticals, Inc. (U.S.), F. Hoffmann-La Roche, Ltd. (Switzerland), Novo Nordisk A/S (Denmark), Orexigen Therapeutics, Inc. (U.S.), Allergan (Republic of Ireland), Cousin Biotech (France), EnteroMedics, Inc. (U.S.), Johnson & Johnson Services, Inc. (U.S.), Medtronic (U.S.), USGI Medical, Inc. (U.S.), Mediflex Surgical Products (U.S.), Covidien plc (Republic of Ireland), Olympus Corporation (Japan), and others.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/obesity-treatment-market-5872
Obesity Treatment Industry News
Intense competition in the private sector has pushed for breakthroughs and innovation in creating cutting-edge obesity treatment procedures available in private hospitals and clinics. As a result, there is a growing need for minimally invasive procedures. Furthermore, the obesity treatment market is being propelled by rising awareness of obesity and its associated disorders and the commercial availability of weight management treatments.
Browse More Related Reports at:
Bariatric Surgery Market Research Report – Forecast to 2027
Obesity Management Market Research Report- Forecast to 2027
Global Bariatric Surgery Devices Market Research Report—Forecast till 2027
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071